Pura Vida Investments

Pura Vida Investments is a New York-based healthcare-focused investment firm and SEC-registered investment adviser that operates as a hedge fund / investment manager. Public sources describe it as market-neutral and oriented toward healthcare and life sciences, with activity across biotech, medical technology, diagnostics, and related therapeutics.

In the psychedelic ecosystem, Pura Vida matters mainly as a public-market and crossover healthcare investor rather than a dedicated psychedelics specialist. It has been named in funding rounds for atai Life Sciences, one of the sector’s best-known public psychedelic companies, which suggests exposure to mental-health and psychedelic-adjacent drug development.

Public materials place Pura Vida Investments in the New York area and describe it as a healthcare-focused, market-neutral investor with a broad life-science remit. Its publicly visible psychedelic relevance is indirect but meaningful: it has participated in at least one major atai Life Sciences financing, aligning the firm with the public-market side of psychedelic and mental-health therapeutics investing.